• Medientyp: E-Artikel
  • Titel: Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice
  • Beteiligte: Contaldo, Claudio; Meier, Christoph; Elsherbiny, Ahmed; Harder, Yves; Trentz, Otmar; Menger, Michael D.; Wanner, Guido A.
  • Erschienen: American Physiological Society, 2007
  • Erschienen in: American Journal of Physiology-Heart and Circulatory Physiology, 293 (2007) 1, Seite H274-H283
  • Sprache: Englisch
  • DOI: 10.1152/ajpheart.01031.2006
  • ISSN: 0363-6135; 1522-1539
  • Schlagwörter: Physiology (medical) ; Cardiology and Cardiovascular Medicine ; Physiology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>Erythropoietin (EPO) has been proposed as a novel cytoprotectant in ischemia-reperfusion (I/R) injury of the brain, heart, and kidney. However, whether EPO exerts its protection by prevention of postischemic microcirculatory deterioration is unknown. We have investigated the effect of EPO on I/R-induced microcirculatory dysfunctions. We used the mouse dorsal skinfold chamber preparation to study nutritive microcirculation and leukocyte-endothelial cell interaction in striated muscle of the dorsal skinfold by in vivo fluorescence microscopy before 3 h of ischemia and during 5 days of reperfusion. Animals were pretreated with EPO (5,000 U/kg body wt) 1 or 24 h before ischemia. Vehicle-treated I/R-injured animals served as controls. Additional animals underwent sham operation only or were pretreated with EPO but not subjected to I/R. I/R significantly ( P &lt; 0.05) reduced functional capillary density, increased microvascular permeability, and enhanced venular leukocyte-endothelial cell interaction during early reperfusion. These findings were associated with pronounced ( P &lt; 0.05) arteriolar constriction and diminution of blood flow during late reperfusion. Pretreatment with EPO induced EPO receptor and endothelial nitric oxide synthase expression at 6 h of reperfusion ( P &lt; 0.05). In parallel, EPO significantly ( P &lt; 0.05) reduced capillary perfusion failure and microvascular hyperpermeability during early reperfusion and arteriolar constriction and flow during late reperfusion. EPO pretreatment substantially ( P &lt; 0.05) diminished I/R-induced leukocytic inflammation by reducing the number of rolling and firmly adhering leukocytes in postcapillary venules. EPO applied 1 h before ischemia induced angiogenic budding and sprouting at 1 and 3 days of reperfusion and formation of new capillary networks at 5 days of reperfusion. Thus our study demonstrates for the first time that EPO effectively attenuates I/R injury by preserving nutritive perfusion, reducing leukocytic inflammation, and inducing new vessel formation.</jats:p>
  • Zugangsstatus: Freier Zugang